Pneumonia caused by Chlamydia pneumoniae
Part of Infections, Lungs & breathing clinical trials.
This study looks back at medical records of people who had pneumonia caused by Chlamydia pneumoniae, a type of bacteria. It aims to learn more about how this infection affects patients, which could help improve care in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Had a diagnosis of pneumonia (lung infection).
- Had a positive test for Chlamydia pneumoniae from a respiratory sample (such as a throat swab or sputum).
- Test was done between January 2015 and December 2025.
- Had enough medical records available for review.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at adults with community-acquired pneumonia, using symptom checks and chest X-ray results. It may help researchers better understand what pneumonia looks like in the community and how it progresses.
This trial looks at which “pneumococcus” (a common germ) types are causing pneumonia in people admitted to the hospital. It uses a urine test kit to see how often different pneumococcal types are involved, which may help future treatment choices.
This trial studies treatment for pneumonia by enrolling people who have pneumonia signs on a chest X-ray plus typical symptoms like fever, cough, trouble breathing, or chest pain. It may help doctors test approaches for better outcomes after pneumonia.
This study looks at the germs in your lungs to understand why some people's pneumonia doesn't get better with standard antibiotics. If you are hospitalized with pneumonia and have just started treatment, you may be asked to provide a sputum sample so researchers can study your lung microbiome.
This study looks at samples from people who have a lung infection called PCP (a type of pneumonia). The goal is to learn more about the germ that causes it, which might lead to better treatments in the future.
This study follows how community-acquired pneumonia progresses in hospitalized patients who already have serious health problems or weakened immune systems. The goal is to better understand risk and changes over time, which may help guide future care for people like you.
Hear when a new Community-acquired Pneumonia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.